Showing 2,669 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment side-effects

Common side-effects of hepatitis C protease inhibitors: clinical management advice published

News
20 January 2012
New & experimental hepatitis C treatment

Achillion's Hep C Pipeline Likely Can't Compete

Editor's pick
BioMed Reports
19 January 2012
Pharmaceutical industry

Bristol-Myers Raised Offer 30% to Beat Competitor for Inhibitex

Editor's pick
Bloomberg Business Week
17 January 2012
Hepatitis C symptoms & diagnosis

France: Is more frequent monitoring for liver cancer among co-infected people needed?

Editor's pick
CATIE
11 January 2012
New & experimental hepatitis C treatment

Idenix Reports Advancement of HCV Development Pipeline

Editor's pick
Idenix (press release)
11 January 2012
New & experimental hepatitis C treatment

Achillion Reports Clinical Data on Portfolio of HCV Protease Inhibitors

Editor's pick
Achillion (press release)
11 January 2012
Pharmaceutical industry

Merck Hepatitis C Drug May `Anchor' Future Worldwide Regimen

Editor's pick
Bloomberg
10 January 2012
Pharmaceutical industry

Bristol Buys Inhibitex for $2.5 Billion to Compete in Hepatitis

Editor's pick
Bloomberg BusinessWeek
9 January 2012
Hepatitis C transmission & prevention

Hepatitis C vaccine: Oxford researchers' trial 'promising'

Editor's pick
BBC
4 January 2012
HIV treatment

Top 10 HIV and Hepatitis Stories of 2011

Editor's pick
HIVandHepatitis.com
3 January 2012
New & experimental hepatitis C treatment

Early guidance on use of hepatitis C protease inhibitors in HIV-co-infected patients

News
29 December 2011
Pharmaceutical industry

The Hepatitis C Market: Biotech’s Version of the Daytona 500

Editor's pick
Xconomy
13 December 2011
Hepatitis B

Co-infection with hepatitis B worsens HIV-related outcomes

News
13 December 2011
Hepatitis B

Hepatitis B genotype B associated with poorer liver-related outcomes in Taiwanese patients co-infected with HIV and hepatitis B

News
13 December 2011
New & experimental hepatitis C treatment

AASLD: High Sustained Response Rates with Danoprevir plus Pegylated Interferon/Ribavirin for HCV

Editor's pick
HIVandHepatitis.com
12 December 2011
Treatment outcomes & life expectancy

Earlier deaths in people with HIV due to drugs, alcohol, co-infections, poorly controlled HIV - not rapid ageing

News
12 December 2011
Neurological & cognitive problems

Hepatitis C doesn't affect cognitive function of women, but some evidence HIV does

News
8 December 2011
Hepatitis C treatment

Poor Liver Transplant Outcomes for HIV/HCV Coinfected Patients

Editor's pick
Medscape (requires free registration)
6 December 2011
Pharmaceutical industry

Pharmasset Poised to Pay 20% With Gilead Deal Closing

Editor's pick
Bloomberg Businessweek
6 December 2011
Hepatitis C treatment

AASLD: Upping Ribavirin Dose Does Not Increase Interferon Effectiveness in HIV/HCV Coinfected Patients

Editor's pick
HIVandHepatitis.com
24 November 2011
Hepatitis & HIV

Hep C deaths outpace HIV; new drugs, services for coinfected

Editor's pick
Bay Area Reporter
23 November 2011
New & experimental hepatitis C treatment

University launches iphone app for hepatitis treatment

Editor's pick
Eurekalert Medicine & Health
22 November 2011
Pharmaceutical industry

HIV Drug Giant Gilead Acquires Pharmasset, a Hep C Drug Development Leader

Editor's pick
AIDSMeds.com
21 November 2011
Hepatitis C transmission & prevention

AASLD: Epidemic of Sexually Transmitted HCV among HIV+ Gay Men in Amsterdam Levels Off

Editor's pick
HIVandHepatitis.com
21 November 2011